IN-STEPIn-Space Technology Experiments Program (NASA)
References in periodicals archive ?
25 March 2010 - UK-based development stage pharmaceutical company Vernalis plc (LON: VER) announced yesterday top-line results from the IN-STEP Phase IIb study, evaluating further the safety and efficacy of V3381 (indantadol) in patients with neuropathic pain due to diabetes.
IN-STEP is a public-private partnership among Kenan Institute Asia, the Ministry of Education, the Institute for the Promotion of Teaching Science & Technology, the Merck Institute for Science Education, and the Consortium for Policy Research in Education (CPRE) at Teachers College.